596
Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS-related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
 acral necrosis: Effect; Raynaud's phenomenon: Effect; bleomycin: Treatment; vinca alkaloids: Treatment; bleomycin: Treatment.Drug; vinca alkaloids: Treatment.Drug; bleomycin: Combination.Drug; vinca alkaloids: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 acral necrosis: Effect; Raynaud's phenomenon: Effect; bleomycin: Treatment; vinca alkaloids: Treatment; bleomycin: Treatment.Drug; vinca alkaloids: Treatment.Drug; bleomycin: Combination.Drug; vinca alkaloids: Combination.Drug